Sequencing AI Automation and Data Interoperability in Oncology Using a Scenario-Planning Framework Coupled With Discrete-Event Simulation: Proof-of-Concept Study - Report - MDSpire

Sequencing AI Automation and Data Interoperability in Oncology Using a Scenario-Planning Framework Coupled With Discrete-Event Simulation: Proof-of-Concept Study

  • By

  • Peter May

  • Sabine D Brookman-May

  • Edward Garrahy

  • Johannes von Büren

  • May 25, 2026

  • 0 min

Share

Integrating AI Automation and Data Interoperability in Oncology

Overview

This report presents a proof-of-concept framework for integrating AI automation and data interoperability in oncology through scenario planning and discrete-event simulation.

Background

The integration of artificial intelligence in oncology is critical as the field faces challenges such as diagnostic throughput and coordination among multidisciplinary teams. Current AI applications are evolving, yet their successful implementation is hindered by issues related to data quality and interoperability.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

['The study combines qualitative scenario planning with discrete-event simulation to analyze AI adoption in oncology.', 'AI automation intensity and data interoperability are identified as key drivers of digital transformation in oncology.', 'Operational quadrants were defined to explore outcomes and risk profiles associated with varying levels of AI integration.', 'Integration challenges often lead to nonlinear effects that can destabilize system-level performance.', 'Governance frameworks are becoming increasingly relevant as AI tools are integrated into oncology practices.']

Clinical Implications

Findings focus on the dynamics of AI automation and data interoperability in oncology.

Conclusion

This proof-of-concept investigation presents a framework for understanding AI integration in oncology.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. The ASCO Post, ASCO20 Virtual Scientific Program, 2020 -- Next-Generation Oncology Highlights
  4. ACR Approves First Practice Parameter for Imaging Artificial Intelligence
  5. FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices | FDA
  6. ONC Releases Common Agreement Version 2.0, Paving the Way for TEFCA Exchange via FHIR - ONC
  7. asco ai in oncology — AI in Oncology: From Diagnosis to Human Connection
  8. ACR Approves First Practice Parameter for Imaging Artificial Intelligence
  9. FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices | FDA
  10. ONC Releases Common Agreement Version 2.0, Paving the Way for TEFCA Exchange via FHIR - ONC - Office of the National Coordinator for Health Information Technology
  11. Home - minimal Common Oncology Data Elements (mCODE) Implementation Guide v4.0.0
  12. Essential Insights for Implementing minimal Common Oncology Data Elements® (mCODE) | HIMSS
  13. CodeX quality measures for cancer: Leveraging FHIR and mCODE to support digital quality measures. | JCO Oncology Practice
  14. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study - ScienceDirect
  15. Human-AI teams to improve accuracy and timeliness of oncology trial prescreening: Preplanned interim analysis of a randomized trial. | Journal of Clinical Oncology
  16. Does artificial intelligence have a place in precision oncology?

Original Source(s)

Related Content